“ Pharmacogenetics of Glucocorticoid Replacement Could Optimize the Treatment of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency ”. Clinics 66, no. 8 (January 1, 2011): 1361–1366. Accessed June 15, 2024. https://www.revistas.usp.br/clinics/article/view/19259.